Man Group’s Fortress Biotech FBIO Stock Holding History

Man Group’s Portfolio FBIO Stock Details FBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$40.9K	Buy	+13,379	New	+$34.5K	﹤0.01%	2315
2026 Q1	–	Sell	-52,653	Closed	-$193K	–	2451
2025 Q4	$193K	Buy	+52,653	New	+$150K	﹤0.01%	2131
2022 Q1	–	Sell	-6,044	Closed	-$227K	–	2222
2021 Q4	$227K	Sell	6,044 -894	-13%	-$39.9K	﹤0.01%	1761
2021 Q3	$335K	Sell	6,938 -1,247	-15%	-$60.9K	﹤0.01%	1626
2021 Q2	$438K	Sell	8,185 -2,361	-22%	-$142K	﹤0.01%	1601
2021 Q1	$558K	Buy	10,546 +5,362	+103%	+$302K	﹤0.01%	1447
2020 Q4	$246K	Sell	5,184 -20	-0.4%	-$866	﹤0.01%	1689
2020 Q3	$315K	Buy	+5,204	New	+$265K	﹤0.01%	1623

Other funds holding FBIO

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $100B AUM 36.93% 1-Year Est. Return

GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return

SAM

Shikiar Asset Management New York $396M AUM 41.06% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Man Group's FBIO Position: Q2 2026 in Review

Man Group opened a new position in Fortress Biotech (FBIO) in Q2 2026: 13,379 shares worth $40.9K. The stake represents ﹤0.01% of the portfolio and ranks #2315 among its holdings. This is a return to the name: Man Group previously reported a position in FBIO as recently as Q4 2025.

Man Group first reported a position in FBIO in Q3 2020 and has held it in 8 quarters since. The position peaked at $558K in Q1 2021. 55 funds tracked by Wall St. Rank hold FBIO as of Q2 2026.

Man Group held 13,379 shares of Fortress Biotech worth $40.9K as of Q2 2026.
Fortress Biotech was a new Man Group position in Q2 2026.
Fortress Biotech made up ﹤0.01% of Man Group's portfolio in Q2 2026, its #2315 holding.
Man Group first reported a position in Fortress Biotech in Q3 2020 and has held it in 8 quarters since.
Man Group's Fortress Biotech position peaked at $558K in Q1 2021.
55 funds tracked by Wall St. Rank held Fortress Biotech as of Q2 2026.

Based on Man Group's 13F filing for Q2 2026, filed 14 Aug 2026.